-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s share price traded up 2.2% on Tuesday . The company traded as high as $9.35 and last traded at $8.87. 1,200,078 shares traded hands during trading, a decline of 64% from the average session volume of 3,376,665 shares. The stock had previously closed at $8.68.
Mind Medicine (MindMed) Stock Performance
The business has a 50-day moving average price of $8.27 and a two-hundred day moving average price of $5.08.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Read More
- Five stocks we like better than Mind Medicine (MindMed)
- What Investors Need to Know About Upcoming IPOs
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Canada Bond Market Holiday: How to Invest and Trade
- Lockheed Martin Stock Aims for a Fresh All-Time High
- The How And Why of Investing in Oil Stocks
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
